2024-10-18 PUT at $90.0 Option on Haemonetics
HAE Stock | USD 75.08 0.41 0.54% |
2024-10-18 PUT at $90.0 is a PUT option contract on Haemonetics' common stock with a strick price of 90.0 expiring on 2024-10-18. The contract was not traded in recent days and, as of today, has 22 days remaining before the expiration. The option is currently trading at a bid price of $12.9, and an ask price of $16.1. The implied volatility as of the 26th of September is 74.47.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Haemonetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Haemonetics Stock refer to our How to Trade Haemonetics Stock guide.
Haemonetics |
A put option written on Haemonetics becomes more valuable as the price of Haemonetics drops. Conversely, Haemonetics' put option loses its value as Haemonetics Stock rises. When exercised, put options on Haemonetics produce a short position in Haemonetics Stock. Because of this protective nature, they are typically used either for hedging purposes or to capitalize on Haemonetics' downside price movement.
Rule 16 of 2024-10-18 Option Contract
The options market is anticipating that Haemonetics will have an average daily up or down price movement of about 4.65% per day over the life of the option. With Haemonetics trading at USD 75.08, that is roughly USD 3.49. If you think that the market is fully understating Haemonetics' daily price movement you should consider buying Haemonetics options at that current volatility level of 74.47%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
In The Money Put Option on Haemonetics
An 'In The Money' option is one with a strike price that the current stock price has already surpassed. Some options investors can hedge their Haemonetics positions using in-the-money options. They may also want to buy options with some intrinsic value, not just time value. However, because in-the-money options on Haemonetics Stock have intrinsic value and are priced higher than out-of-the-money options in the same chain, their volatilities are relatively smaller.
Put Contract Name | 2024-10-18 PUT at $90.0 |
Expires On | 2024-10-18 |
Days Before Expriration | 22 |
Last Traded On | 0000-00-00 00:00:00 |
Contract Period | MONTHLY |
Open Interest | 0 |
Current Trading Volume | 0.0 |
Strike Price | 90.0 |
Last Traded At | 0.0 |
Current Price Spread | 12.9 | 16.1 |
Rule 16 Daily Up or Down | USD3.49 |
Haemonetics short PUT Option Greeks
Haemonetics' Option Greeks for the contract ending on 2024-10-18 at a strike price of 90.0 measures the various factors that affect its cost and calculated using a theoretical options pricing model. It helps investors make more informed decisions about whether to trade this option contract or when to trade it. In addition to Haemonetics' option greeks, its implied volatility helps estimate the risk of Haemonetics stock implied by the prices of the options on Haemonetics' stock.
Delta | -0.8099 | |
Gamma | 0.0196 | |
Theta | -0.0756 | |
Vega | 0.051 | |
Rho | -0.0329 |
Haemonetics long PUT Option Payoff at expiration
Put options written on Haemonetics grant holders of the option the right to sell a specified amount of Haemonetics at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Haemonetics Stock cannot fall below zero, the put buyer does gain as the price drops. So, purchasing a put option on Haemonetics is like buying insurance aginst Haemonetics' downside shift.
Profit |
Haemonetics Price At Expiration |
Haemonetics short PUT Option Payoff at expiration
By selling Haemonetics' put option, the investors signal their bearish sentiment. A short position in a put option written on Haemonetics will generally make money when the underlying price is above the strike price. Therefore Haemonetics' put payoff at expiration depends on where the Haemonetics Stock price is relative to the put option strike price. The breakeven price of 73.9 is the critical point that divides the payoff function into two parts. Below the breakeven price, the payoff is dropping and negative (the seller makes a loss). Above the breakeven price, the payoff line is upward sloping as the option payoff increases in proportion to Haemonetics' price. Finally, at the strike price of 90.0, the payoff chart is constant and positive.
Profit |
Haemonetics Price At Expiration |
Haemonetics Available Put Options
Haemonetics' option chain is a display of a range of information that helps investors for ways to trade options on Haemonetics. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Haemonetics. It also shows strike prices and maturity days for a Haemonetics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Put | 2024-10-18 PUT at $65.0 | -0.0824 | 0.0184 | 6 | 2024-10-18 | 0.05 - 0.6 | 0.9 | Out |
Put | 2024-10-18 PUT at $70.0 | -0.1945 | 0.0413 | 13 | 2024-10-18 | 0.45 - 1.05 | 0.55 | Out |
Put | 2024-10-18 PUT at $75.0 | -0.4673 | 0.0731 | 72 | 2024-10-18 | 1.8 - 2.3 | 1.28 | Out |
Put | 2024-10-18 PUT at $80.0 | -0.7943 | 0.0528 | 11 | 2024-10-18 | 4.1 - 6.7 | 6.13 | In |
Put | 2024-10-18 PUT at $85.0 | -0.7454 | 0.0261 | 0 | 2024-10-18 | 8.0 - 11.5 | 0.0 | In |
Put | 2024-10-18 PUT at $90.0 | -0.8099 | 0.0196 | 0 | 2024-10-18 | 12.9 - 16.1 | 0.0 | In |
Put | 2024-10-18 PUT at $95.0 | -0.9599 | 0.0087 | 0 | 2024-10-18 | 17.9 - 22.1 | 0.0 | In |
Put | 2024-10-18 PUT at $100.0 | -0.9791 | 0.0046 | 0 | 2024-10-18 | 22.8 - 27.1 | 0.0 | In |
Put | 2024-10-18 PUT at $105.0 | -0.9675 | 0.0055 | 0 | 2024-10-18 | 27.9 - 32.1 | 0.0 | In |
Put | 2024-10-18 PUT at $110.0 | -0.8211 | 0.0101 | 0 | 2024-10-18 | 32.9 - 36.9 | 0.0 | In |
Haemonetics Corporate Directors
Robert Abernathy | Independent Director | Profile | |
Claire Pomeroy | Independent Director | Profile | |
Catherine Burzik | Independent Director | Profile | |
Mark Kroll | Independent Director | Profile |
Additional Information and Resources on Investing in Haemonetics Stock
When determining whether Haemonetics is a strong investment it is important to analyze Haemonetics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Haemonetics' future performance. For an informed investment choice regarding Haemonetics Stock, refer to the following important reports:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Haemonetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Haemonetics Stock refer to our How to Trade Haemonetics Stock guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Haemonetics. If investors know Haemonetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Haemonetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.07) | Earnings Share 2.23 | Revenue Per Share 26.255 | Quarterly Revenue Growth 0.08 | Return On Assets 0.0609 |
The market value of Haemonetics is measured differently than its book value, which is the value of Haemonetics that is recorded on the company's balance sheet. Investors also form their own opinion of Haemonetics' value that differs from its market value or its book value, called intrinsic value, which is Haemonetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Haemonetics' market value can be influenced by many factors that don't directly affect Haemonetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Haemonetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Haemonetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Haemonetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.